After my last chat with Peter Bakema, President and CEO of CVR Medical (TSX.V:CVM, OTCQB CRRVF) there were a couple questions that I received asking for some more clarity on timelines to FDA clearance and the need for additional trials. To get these questions answered I have the Chief Operations Officer Tony Robins join me on the show. We discuss the upcoming trials and path/timeline to FDA clearance.

If you have any follow up questions to the CVR team please comment or email me directly – Fleck@kereport.com.

Click here to visit the CVR website.

Click download link to listen on this device: Download Show